Who
Richard T. LeBuhn
Director
Company insider
Files Form 4 as: Director, STAAR Surgical; Director, Asterias Biotherapeutics; Director, Comarco.
In numbers
- Trades disclosed
- 25
- Buys
- 4
- Sells
- 0
- Bought
- $95K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Mar 2008
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —11,145 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —11,145 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —7,524 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | STAA STAAR Surgicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —7,524 at $0.00 | filing |
| 21 Jun 2018filed 25 Jun 2018 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 30 Mar 2017filed 3 Apr 2017 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 27 Oct 2016filed 31 Oct 2016 | Comarcooption or derivative | SEC FORM 4 Code A | —24,047 at $0.00 | filing |
| 27 Oct 2016filed 31 Oct 2016 | Comarcooption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 29 Jun 2016filed 1 Jul 2016 | Asterias Biotherapeutics | SEC FORM 4 Bought | $12K5,000 at $2.38 | filing |
| 13 May 2016filed 17 May 2016 | Asterias Biotherapeutics | SEC FORM 4 Bought | $51K15,000 at $3.39 | filing |
| 13 May 2016filed 17 May 2016 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code P | $757,500 at $0.01 | filing |
| 28 Feb 2016filed 1 Mar 2016 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 9 Jul 2015filed 13 Jul 2015 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 Jun 2015filed 26 Jun 2015 | Asterias Biotherapeutics | SEC FORM 4 Bought | $22K5,000 at $4.41 | filing |
| 17 Jun 2015filed 19 Jun 2015 | Comarcooption or derivative | SEC FORM 4 Code A | —25,953 at $0.00 | filing |
| 10 Apr 2014filed 14 Apr 2014 | Asterias Biotherapeuticsoption or derivative | SEC FORM 4 Code J | —20,000 at $0.00 | filing |
| 8 Oct 2013filed 9 Oct 2013 | Comarco | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 21 Feb 2013filed 22 Feb 2013 | Comarco | SEC FORM 4 Bought | $10K62,500 at $0.16 | filing |
| 18 Oct 2012filed 22 Oct 2012 | Comarcooption or derivative | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 21 Jul 2011filed 25 Jul 2011 | Comarco | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.